Sign in
4/A

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-24-001139

Options or other derivatives

  • CEO, Pres., CFO Treas & Secty acquired 2,778 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Francis Knuettel II CEO, Pres., CFO Treas & Secty 2024-02-21 Grant or award · Employee Stock Option +2,778 25,001 I: show line 1 in the form
Loading xslF345X05/ownership.xml…